53 related articles for article (PubMed ID: 2557421)
1. Effects of delta-9-tetrahydrocannabinol on sensory evoked hippocampal activity in the rat: principal components analysis and sequential dependency.
Hampson RE; Foster TC; Deadwyler SA
J Pharmacol Exp Ther; 1989 Dec; 251(3):870-7. PubMed ID: 2557421
[TBL] [Abstract][Full Text] [Related]
2. delta 9-Tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat dentate gyrus.
Campbell KA; Foster TC; Hampson RE; Deadwyler SA
J Pharmacol Exp Ther; 1986 Dec; 239(3):936-40. PubMed ID: 3025423
[TBL] [Abstract][Full Text] [Related]
3. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells.
Heyser CJ; Hampson RE; Deadwyler SA
J Pharmacol Exp Ther; 1993 Jan; 264(1):294-307. PubMed ID: 8380864
[TBL] [Abstract][Full Text] [Related]
4. Effects of delta 9-tetrahydrocannabinol on sensory-evoked discharges of granule cells in the dentate gyrus of behaving rats.
Campbell KA; Foster TC; Hampson RE; Deadwyler SA
J Pharmacol Exp Ther; 1986 Dec; 239(3):941-5. PubMed ID: 3025424
[TBL] [Abstract][Full Text] [Related]
5. Interaction between impulse-flow and delta 9-tetrahydrocannabinol within the septal-hippocampal cholinergic pathway of rat brain.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1981 Nov; 219(2):580-4. PubMed ID: 6270316
[TBL] [Abstract][Full Text] [Related]
6. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats.
Holson RR; Ali SF; Scallet AC; Slikker W; Paule MG
Neurotoxicology; 1989; 10(3):605-19. PubMed ID: 2576305
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and electrophysiological effects of delta-9-THC in rats.
Deadwyler S; Heyser C; Michaelis R; Hampson R; Breese C
NIDA Res Monogr; 1988; 90():223-33. PubMed ID: 2855855
[No Abstract] [Full Text] [Related]
9. Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.
Fadda P; Robinson L; Fratta W; Pertwee RG; Riedel G
Neuropharmacology; 2004 Dec; 47(8):1170-9. PubMed ID: 15567426
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter concentrations and receptor binding in the rat brain.
Ali SF; Newport GD; Scallet AC; Gee KW; Paule MG; Brown RM; Slikker W
Neurotoxicology; 1989; 10(3):491-500. PubMed ID: 2576303
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
Boucher AA; Vivier L; Metna-Laurent M; Brayda-Bruno L; Mons N; Arnold JC; Micheau J
Behav Pharmacol; 2009 Feb; 20(1):45-55. PubMed ID: 19179850
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
Kolb B; Gorny G; Limebeer CL; Parker LA
Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
17. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
Shi LH; Luo F; Woodward DJ; Chang JY
Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
[TBL] [Abstract][Full Text] [Related]
18. Despite strong behavioral disruption, Delta9-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus.
Kochman LJ; dos Santos AA; Fornal CA; Jacobs BL
Brain Res; 2006 Oct; 1113(1):86-93. PubMed ID: 16930565
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal function during behaviorally silent associative learning: dissociation of memory storage and expression.
Talk AC; Gandhi CC; Matzel LD
Hippocampus; 2002; 12(5):648-56. PubMed ID: 12440579
[TBL] [Abstract][Full Text] [Related]
20. delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.
Oishi R; Itoh Y; Nishibori M; Saeki K
J Pharmacol Exp Ther; 1985 Feb; 232(2):513-8. PubMed ID: 2578567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
